Interleukin-6 (Ajinomoto)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-6 (Ajinomoto)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionInterleukin-6 receptor alpha subunit agonistsInterleukin-6 receptor subunit beta agonists

TargetsInterleukin-6 receptor alpha subunitInterleukin-6 receptor subunit beta

Therapy Area/IndicationsThrombocytopenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAjinomoto Co Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAjinomoto Co Inc

Active IndicationsN/A

Inactive IndicationsThrombocytopenia

ATC CodeN/A